IN2013MU01239A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01239A
IN2013MU01239A IN1239MU2013A IN2013MU01239A IN 2013MU01239 A IN2013MU01239 A IN 2013MU01239A IN 1239MU2013 A IN1239MU2013 A IN 1239MU2013A IN 2013MU01239 A IN2013MU01239 A IN 2013MU01239A
Authority
IN
India
Prior art keywords
methylphenidate
salts
relates
present
modified release
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Jitendrakumar Chordiya
Inderjeetsingh Huda
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1239MU2013 priority Critical patent/IN2013MU01239A/en
Publication of IN2013MU01239A publication Critical patent/IN2013MU01239A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1239MU2013 2013-03-29 2013-03-29 IN2013MU01239A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1239MU2013 IN2013MU01239A (ru) 2013-03-29 2013-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1239MU2013 IN2013MU01239A (ru) 2013-03-29 2013-03-29

Publications (1)

Publication Number Publication Date
IN2013MU01239A true IN2013MU01239A (ru) 2015-04-17

Family

ID=54395621

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1239MU2013 IN2013MU01239A (ru) 2013-03-29 2013-03-29

Country Status (1)

Country Link
IN (1) IN2013MU01239A (ru)

Similar Documents

Publication Publication Date Title
PH12019502355A1 (en) Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
TN2015000278A1 (en) Autotaxin inhibitors
IN2014DN09434A (ru)
BR112015003188A2 (pt) Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente
MX365939B (es) Moduladores del transporte nuclear y usos de los mismos.
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
GB201118656D0 (en) New compounds
MX2013012053A (es) Inhibidores de replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
MX2015004362A (es) Derivados de ketamina.
JO3122B1 (ar) مشتقات إسترا-5،3،1(10)، 16- تترايين-3- كربوكساميد، عمليات لتحضيرها، مستحضرات دوائية تشتمل عليها واستخدامها لتحضير أدوية
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2015008187A (es) Inhibidores de alk deuterados.
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
GB201115977D0 (en) Neurodevelopmental disorders
IN2013MU01239A (ru)
IN2013MU01243A (ru)
IN2013MU01240A (ru)
IN2013MU01241A (ru)
IN2013MU01242A (ru)
IN2013MU01244A (ru)